We are live on ! Find out more
ZSAN

Zosano Pharma Corporation
ZSAN

Delisted

ZSAN was delisted on the 10th of June, 2022.

Back to rankings

15 hedge funds and large institutions have $25.3M invested in Zosano Pharma Corporation in 2015 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

6% less funds holding

Funds holding: 16 → 15 (-1)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

45% less capital invested

Capital invested by funds: $46.1M → $25.3M (-$20.8M)

60% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 5

Holders
15
Holders Change
-1
Holders Change %
-6.25%
% of All Funds
0.42%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
3
Increased
2
Reduced
5
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
GTC
Ghost Tree Capital
New York
+$802K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$724K
3
LOAMU
Lombard Odier Asset Management (USA)
New York
+$505K
4
EAM
Eventide Asset Management
Massachusetts
+$44.9K
5
TRCT
Tower Research Capital (TRC)
New York
+$5.61K

Top Sellers

Rank Fund Capital Flow
1
BC
Broadfin Capital
New York
-$909K
2
SFM
Sphera Funds Management
Israel
-$452K
3
ACP
Acuta Capital Partners
California
-$112K
4
Millennium Management
Millennium Management
New York
-$90K
5
SM
Sabby Management
Florida
-$78.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
NMC
1
NEA Management Company
Maryland
$8.55M – – –
Fidelity Investments
2
Fidelity Investments
Massachusetts
$3.96M – – –
EAM
3
Eventide Asset Management
Massachusetts
$3.5M +$44.9K +8 +0.6%
LOAMU
4
Lombard Odier Asset Management (USA)
New York
$1.89M +$505K +90 +15%
VAM
5
Visium Asset Management
New York
$1.64M -$78.6K -14 -2%
PI
6
Putnam Investments
Massachusetts
$1.58M – – –
BC
7
Broadfin Capital
New York
$1.47M -$909K -162 -23%
PAI
8
ProQuest Associates IV
Florida
$910K – – –
SM
9
Sabby Management
Florida
$647K -$78.6K -14 -6%
GTC
10
Ghost Tree Capital
New York
$396K +$802K +143 New
Vanguard Group
11
Vanguard Group
Pennsylvania
$359K +$724K +129 New
ACP
12
Acuta Capital Partners
California
$292K -$112K -20 -16%
KCM
13
Knoll Capital Management
Florida
$74K -$11.2K -2 -7%
BIM
14
BlackRock Investment Management
Delaware
$3K – – –
TRCT
15
Tower Research Capital (TRC)
New York
$3K +$5.61K +1 New
SFM
16
Sphera Funds Management
Israel
– -$452K -89 Closed
Millennium Management
17
Millennium Management
New York
– -$90K -18 Closed
Deutsche Bank
18
Deutsche Bank
Germany
– -$41K -8 Closed
UBS Group
19
UBS Group
Switzerland
– -$6K -1 Closed

ZSAN Hedge Fund Activity: Q3 2015 in Review

15 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Zosano Pharma Corporation (ZSAN) for Q3 2015, worth a combined $25.3M — down 45% from $46.1M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of ZSAN and 3 opened new positions — a net loss of 1 holder — while 5 trimmed existing stakes and 2 added.

The largest buyer was Ghost Tree Capital, opening a new position worth an estimated $802K. The largest seller was Broadfin Capital, cutting an estimated $909K.

  • 15 institutional investors held Zosano Pharma Corporation (ZSAN) as of Q3 2015, down from 16 in Q2 2015.
  • Funds reported $25.3M of Zosano Pharma Corporation stock for Q3 2015, down 45% quarter-over-quarter.
  • 3 funds opened new Zosano Pharma Corporation positions in Q3 2015 and 4 closed out, a net change of -1 holder.
  • The largest Zosano Pharma Corporation buyer in Q3 2015 was Ghost Tree Capital, an estimated $802K added.
  • The largest Zosano Pharma Corporation seller in Q3 2015 was Broadfin Capital, an estimated $909K sold.

Based on aggregated 13F filings for Q3 2015.